Consistent with the proteomics results, PEPD and IGFBP3 showed a decreasing trend in a limited number of samples ( Figures 4E,F ).
← all excerpts
Discovering new peripheral plasma biomarkers to identify cognitive decline in type 2 diabetes.
1
—
—
Consistent with the proteomics results, PEPD and IGFBP3 showed a decreasing trend in a limited number of samples ( Figures 4E,F ).